1,044
Views
30
CrossRef citations to date
0
Altmetric
Review

Emerging treatments for Alzheimer’s disease for non-amyloid and non-tau targets

, &
Pages 683-695 | Received 13 Oct 2016, Accepted 02 May 2017, Published online: 18 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alexandre A. de Castro, Flávia V. Soares, Ander F. Pereira, Daniel A. Polisel, Melissa S. Caetano, Daniel H. S. Leal, Elaine F. F. da Cunha, Eugenie Nepovimova, Kamil Kuca & Teodorico C. Ramalho. (2019) Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease. Expert Review of Neurotherapeutics 19:5, pages 375-395.
Read now

Articles from other publishers (29)

Tanzeel Khan, Rashid Waseem, Mohammad Shahid, Jaoud Ansari, Ishfaq Ahmad Ahanger, Imtaiyaz Hassan & Asimul Islam. (2023) Recent advancement in therapeutic strategies for Alzheimer’s disease: Insights from clinical trials. Ageing Research Reviews 92, pages 102113.
Crossref
Paloma Garcia-Casas, Michela Rossini, Riccardo Filadi & Paola Pizzo. (2023) Mitochondrial Ca2+ signaling and Alzheimer's disease: Too much or too little?. Cell Calcium 113, pages 102757.
Crossref
Minqi Chen, Jinyue Liang, Yi Liu, Yayue Liu, Chunxia Zhou, Pengzhi Hong, Yi Zhang & Zhong-Ji Qian. (2023) The Mechanism of Two Benzaldehydes from Aspergillus terreus C23-3 Improve Neuroinflammatory and Neuronal Damage to Delay the Progression of Alzheimer’s Disease. International Journal of Molecular Sciences 24:2, pages 905.
Crossref
G. Vijendar Reddy, B. Siva Manga Raju, K. Varshith, S. Sahil & L. Harsha Vardhan. (2023) Alzheimer’s Disease Recognition Applying Non-Negative Matrix Factorization Characteristics from Brain Magnetic Resonance Images (MRI). E3S Web of Conferences 391, pages 01047.
Crossref
Shang-Der Chen, Yao-Chung Chuang, Tsu-Kung Lin & Jenq-Lin Yang. (2023) Alternative role of glucagon-like Peptide-1 receptor agonists in neurodegenerative diseases. European Journal of Pharmacology 938, pages 175439.
Crossref
Huan Lao & Xuejun Zhang. (2022) Diagnose Alzheimer's disease by combining 3D discrete wavelet transform and 3D moment invariants. IET Image Processing 16:14, pages 3948-3964.
Crossref
Nikita Arnst, Nelly Redolfi, Annamaria Lia, Martina Bedetta, Elisa Greotti & Paola Pizzo. (2022) Mitochondrial Ca2+ Signaling and Bioenergetics in Alzheimer’s Disease. Biomedicines 10:12, pages 3025.
Crossref
Shen Ning, Mehdi Jorfi, Shaun R. Patel, Doo Yeon Kim & Rudolph E. Tanzi. (2022) Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease. Frontiers in Neuroscience 16.
Crossref
Huan Lao & Xuejun Zhang. (2022) Regression and Classification of Alzheimer’s Disease Diagnosis Using NMF-TDNet Features From 3D Brain MR Image. IEEE Journal of Biomedical and Health Informatics 26:3, pages 1103-1115.
Crossref
Micha M. M. Wilhelmus, Elisa Tonoli, Clare Coveney, David J. Boocock, Cornelis A. M. Jongenelen, John J. P. Brevé, Elisabetta A. M. Verderio & Benjamin Drukarch. (2022) The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease. Cells 11:3, pages 389.
Crossref
Hao Liu, Yu-Cong Zhou & Wei Song. (2021) Involvement of IL-10R/STAT3 pathway in amyloid β clearance by microlgia in Alzheimer's disease. International Immunopharmacology 101, pages 108263.
Crossref
Shang-Der Chen, Jenq-Lin Yang, Yi-Heng Hsieh, Tsu-Kung Lin, Yi-Chun Lin, A-Ching Chao & Ding-I Yang. (2021) Potential Roles of Sestrin2 in Alzheimer’s Disease: Antioxidation, Autophagy Promotion, and Beyond. Biomedicines 9:10, pages 1308.
Crossref
Ye Ji Jeong, Yeonghoon Son, Hye-Jin Park, Se Jong Oh, Jae Yong Choi, Young-Gyu Ko & Hae-June Lee. (2021) Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model. International Journal of Molecular Sciences 22:17, pages 9374.
Crossref
Michela Rossini, Paloma García-Casas, Riccardo Filadi & Paola Pizzo. (2021) Loosening ER–Mitochondria Coupling by the Expression of the Presenilin 2 Loop Domain. Cells 10:8, pages 1968.
Crossref
Huan Lao, Xuejun Zhang, Yanyan Tang & Chan Liang. (2021) Alzheimer's disease diagnosis based on the visual attention model and equal‐distance ring shape context features. IET Image Processing 15:10, pages 2351-2362.
Crossref
Karolina Drabik, Karolina Piecyk, Artur Wolny, Lidia Szulc‐Dąbrowska, Grażyna Dębska‐Vielhaber, Stefan Vielhaber, Jerzy Duszyński, Dominika Malińska & Joanna Szczepanowska. (2021) Adaptation of mitochondrial network dynamics and velocity of mitochondrial movement to chronic stress present in fibroblasts derived from patients with sporadic form of Alzheimer’s disease. The FASEB Journal 35:6.
Crossref
Jacques Hugon & Claire Paquet. (2021) The PKR/P38/RIPK1 Signaling Pathway as a Therapeutic Target in Alzheimer’s Disease. International Journal of Molecular Sciences 22:6, pages 3136.
Crossref
Clive Ballard, Dag Aarsland, Jeffrey Cummings, John O’Brien, Roger Mills, Jose Luis Molinuevo, Tormod Fladby, Gareth Williams, Pat Doherty, Anne Corbett & Janet Sultana. (2020) Drug repositioning and repurposing for Alzheimer disease. Nature Reviews Neurology 16:12, pages 661-673.
Crossref
Lei Du, Zifang Zhao, Boyan Xu, Wenwen Gao, Xiuxiu Liu, Yue Chen, Yige Wang, Jian Liu, Bing Liu, Shilong Sun, Guolin Ma & Jiahong Gao. (2020) Anisotropy of Anomalous Diffusion Improves the Accuracy of Differentiating and Grading Alzheimer's Disease Using Novel Fractional Motion Model. Frontiers in Aging Neuroscience 12.
Crossref
Lei Du, Boyan Xu, Zifang Zhao, Xiaowei Han, Wenwen Gao, Sumin Shi, Xiuxiu Liu, Yue Chen, Yige Wang, Shilong Sun, Lu Zhang, Jiahong Gao & Guolin Ma. (2020) Identification and Classification of Alzheimer’s Disease Patients Using Novel Fractional Motion Model. Frontiers in Neuroscience 14.
Crossref
Yeonghoon Son, Ye Ji Jeong, Na-Rae Shin, Se Jong Oh, Kyung Rok Nam, Hyung-Do Choi, Jae Yong Choi & Hae-June Lee. (2020) Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice. International Journal of Molecular Sciences 21:15, pages 5553.
Crossref
Alexander Vaiserman, Alexander Koliada & Oleh Lushchak. (2020) Neuroinflammation in pathogenesis of Alzheimer’s disease: Phytochemicals as potential therapeutics. Mechanisms of Ageing and Development 189, pages 111259.
Crossref
Patrick Dallemagne & Christophe Rochais. (2020) Facing the complexity of Alzheimer's disease. Future Medicinal Chemistry 12:3, pages 175-177.
Crossref
Gustavo Provensi, Fabrizio Carta, Alessio Nocentini, Claudiu T. Supuran, Fiorella Casamenti, M. Beatrice Passani & Silvia Fossati. (2019) A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer’s Disease. International Journal of Molecular Sciences 20:19, pages 4724.
Crossref
Rui Dong, Hong Wang, Jishi Ye, Mingshan Wang & Yanlin Bi. (2019) Publication Trends for Alzheimer's Disease Worldwide and in China: A 30-Year Bibliometric Analysis. Frontiers in Human Neuroscience 13.
Crossref
Sales, Prandi, Castro, Leal, Cunha, Kuca & Ramalho. (2019) Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments. International Journal of Molecular Sciences 20:8, pages 1829.
Crossref
Christian Salvatore, Antonio Cerasa & Isabella Castiglioni. (2018) MRI Characterizes the Progressive Course of AD and Predicts Conversion to Alzheimer’s Dementia 24 Months Before Probable Diagnosis. Frontiers in Aging Neuroscience 10.
Crossref
Sergey O. Bachurin, Svetlana I. Gavrilova, Anna Samsonova, George E. Barreto & Gjumrakch Aliev. (2018) Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention. Pharmacological Research 129, pages 216-226.
Crossref
Senthilkumar Krishnaswamy, Qian Wu, Yan Lin, Wajitha J. Rajamohamedsait, Hameetha B. Rajamohamedsait & Einar M. Sigurdsson. 2018. Amyloid Proteins. Amyloid Proteins 513 526 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.